Preview

Вестник аритмологии

Расширенный поиск

Возможности и меры безопасности использования физиотерапии у пациентов с имплантированными антиаритмическими устройствами

https://doi.org/10.35336/VA-2020-4-17-23

Полный текст:

Аннотация

Рассматриваются факторы, способные потенциально вызвать электромагнитную интерференцию (ЭМИ) имплантируемых антиаритмических устройств (ИАУ) при проведении различных методов физиотерапии. Обсуждаются механизмы дисфункций ИАУ, вызванных ЭМИ, и меры безопасности использования физиотерапевтического лечения.

Об авторах

Б. Г. Искендеров
Пензенский институт усовершенствования врачей - филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия

Искендеров Бахрам Гусейнович

Пенза



Т. В. Лохина
Пензенский институт усовершенствования врачей - филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия
Пенза


И. Н. Можжухина
Пензенский институт усовершенствования врачей - филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия
Пенза


А. В. Зайцева
Пензенский институт усовершенствования врачей - филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия
Пенза


Список литературы

1. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2013;34(29):2281-329. DOI: 10.1093/europace/eut206.

2. Ревишвили АШ, Шляхто ЕВ, Попов СВ, и др. Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. М., 2017:156-76.

3. de Vries LM, Dijk WA, Hooijschuur CA, et al. Utilisation of cardiac pacemakers over a 20-year period: Results from a nationwide pacemaker registry. Neth Heart J. 2017;25(1): 47-55. DOI: 10.1007/s12471-016-0880-0.

4. Marinskis G, van Erven L, Bongiorni MG, et al. Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Europace. 2012;14: 423-25. DOI: 10.1093/europace/eus020.

5. Iliou MC, Blanchard JC, Lamar-Tanguy A, et al. Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators. Monaldi Arch Chest Dis. 2016;86(1-2): 756-62. DOI: 10.4081/monaldi.2016.756.

6. Digby GC, Daubney ME, Baggs J, et al. Physiotherapy and cardiac rhythm devices: a review of the current scope of practice. Europace. 2009;11(7):850-59. DOI: 10.1093/europace/eup102.

7. Belyaev I, Dean A, Eger H, et al. EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses. Rev Environ Health. 2016;31(3): 363-97. DOI: 10.1515/reveh-2016-0011.

8. King J, Anderson CM. Patient safety and physiotherapy: What does it mean for your clinical practice? Physiother Can. 2010;62(3): 172-75. DOI: 10.3138/physio.62.3.172.

9. Lim WY, Prabhu S, Schilling RJ. Implantable cardiac electronic devices in the elderly population. Arrhythm Electrophysiol Rev. 2019;8(2): 143-46. DOI: 10.15420/aer.2019.3.4.

10. Badger J, Taylor P, Swain I. The safety of electrical stimulation in patients with pacemakers and implantable cardioverter defibrillators: A systematic review. J Rehabil Assist Technol Eng. 2017;4: 1-9. DOI: 10.1177%2F2055668317745498.

11. Digby GC, Femenía F, Baranchuk A. Cardiac implantable devices and physiotherapy practices interaction: myth or real? Medicina. 2011;1(2): 174-78.

12. Czermak T, Fichtner S. Cardiac implantable electronic devices: electromagnetic interference from electrocauterization, lithotripsy and physiotherapy. Herzschrittmacherther Elektrophysiol. 2019;30(2): 168-76. DOI: 10.1007/s00399-019-0620-4.

13. Vardas PE, Simantirakis EN, Kanoupakis EM. New developments in cardiac pacemakers. Circulation. 2013;127(23):2343-50. DOI: 10.1161/CIRCULATIONAHA.112.000086

14. Greenspon AJ, Patel JD, Lau E, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. JACC. 2012;60: 1540-45. DOI: 10.1016/j.jacc.2012.07.017.

15. Kamiya K, Satoh A, Niwano S, et al. Safety of neuromuscular electrical stimulation in patients implanted with cardioverter defibrillators. J Electrocardiol. 2016;49: 99-101. DOI: 10.1016/j.jelectrocard.2015.11.006.

16. Misiri J, Kusumoto F, Goldschlager N. Electromagnetic interference and implanted cardiac devices: the medical environment (part II). Clin Cardiol. 2012;35: 321-28. DOI: 10.1002/clc.21997.

17. Corzani A, Ziacchi M, Biffi M, et al. Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices. J Cardiovasc Med. 2015;16(10): 704-13. DOI: 10.2459/jcm.0000000000000301.

18. Egger F, Hofer C, Hammerle FP, et al. Influence of electrical stimulation therapy on permanent pacemaker function. Wien Klin Wochenschr. 2019;131(13-14): 313-20. DOI: 10.1007/s00508-019-1494-5.

19. Yildiz BS, Findikoglu G, Alihanoglu YI, et al. How do patients understand safety for cardiac implantable devices? Importance of postintervention education. Rehabil Res Pract. 2018;2018: 5689353. DOI: 10.1155/2018/5689353.

20. Das A., Kahali D. Physiological cardiac pacing: current status. Indian Heart J. 2016;68(4): 552-58. DOI: 10.1016/j.ihj.2016.03.033.

21. Steffen MM, Osborn JS, Cutler MJ. Cardiac implantable electronic device therapy: permanent pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization devices. Med Clin North Am. 2019;103(5):931-43. DOI: 10.1016/j.mcna.2019.04.005.

22. Tjong FV, Reddy VY. Permanent leadless cardiac pacemaker therapy. Circulation. 2017;135(15): 1458-70. DOI: 10.1161/CIRCULATIONAHA.116.025037.

23. Искендеров БГ, Лохина ТВ, Беренштейн НВ. Безопасность использования лечебно-диагностических процедур, вызывающих электромагнитную интерференцию у пациентов с имплантированными электрокардиостимуляторами. Международный журнал сердца и сосудистых заболеваний. 2020;8(27):50-9.

24. Beinart R, Nazarian S. Effects of external electrical and magnetic fields on pacemakers and defibrillators. Circulation. 2013;128: 2799-809. DOI: 10.1161/CIRCULATIONAHA.113.005697.

25. Seckler T, Stunder D, Schikowsky Ch, et al. Effect of lead position and orientation on electromagnetic interference in patients with bipolar cardiovascular implantable electronic devices. Europace. 2017;19(2): 319-28. DOI: 10.1093/europace/euv458.

26. Gercek C, Kourtiche D, Nadi M, et al. Computation of pacemaker’s immunity to 50 Hz electric field: Induced voltages 10 times greater in unipolar than in bipolar detection mode. Bioengineering. 2017;4(1): 19-34. DOI: 10.3390/bioengineering4010019.

27. von Olshausen G, Rondak IC, Lennerz C, et al. Electromagnetic interference in implantable cardioverter defibrillators: present but rare. Clin Res Cardiol. 2016;105:657-65. DOI: 10.1007/s00392-019-01589-6.

28. Raitt MH. Inappropriate implantable defibrillator shocks: an adverse outcome that can be prevented. JACC. 2013;62(15): 1351-52. DOI: 10.1016/j.jacc.2013.05.055.

29. Katrib J, Nadi M, Kourtiche D, et al. In vitro assessment of the immunity of implantable cardioverter-defibrillators to magnetic fields of 50/60 Hz. Physiol Meas. 2013;34(10):1281-92. DOI: 10.1088/0967-3334/34/10/1281.

30. Napp A, Stunder D, Ma M, et al. Are patients with cardiac implants protected against electromagnetic interference in daily life and occupational environment? Eur Heart J. 2015; 36: 1798-804. DOI: 10.1093/eurheartj/ehv135.

31. Tseng ZH, Hayward RM, Clark NM, et al. Sudden death in patients with cardiac implantable electronic devices. JAMA Intern Med. 2015;175(8): 1342-50. DOI: 10.1001/jamainternmed.2015.2641.

32. Chemello D, Pivatto JF, Pimentel M, et al. Development of ventricular fibrillation after implantation of a biventricular implantable cardioverter defibrillator: what is the mechanism? Clin Case Rep. 2017;5(7): 1176-80. DOI: 10.1002/ccr3.1020.

33. Tiikkaja M, Aro AL, Alanko T, et al. Electromagnetic interference with cardiac pacemakers and implantable cardioverter- defibrillators from low-frequency electromagnetic fields in vivo. Europace. 2013;15(3): 388-94. DOI: 10.1093/europace/eus345.

34. Driessen S, Napp A, Schmiedchen K, et al. Electromagnetic interference in cardiac electronic implants caused by novel electrical appliances emitting electromagnetic fields in the intermediate frequency range: a systematic review. Europace. 2019;21(2): 219-29. DOI: 10.1093/europace/euy155.

35. Ribatti V, Santini L, Forleo GB, et al. Electromagnetic interference in the current era of cardiac implantable electronic devices designed for magnetic resonance environment. G Ital Cardiol. 2017;18(4):295-304. DOI: 10.1714/2683.27472.

36. Пономаренко ГН. Общая физиотерапия. - Москва: ГЭОТАР-Медиа; 2013:109-71.

37. Kulinski W. Physiotherapy in patients with an implanted cardiac pacemaker. Polish J Physiotherapy. 2017;17(3):28-36.

38. Yildiz BS, Findikoglu G, Sanlialp M. A survey of awareness for patients living with cardiac implantable devices. J Int Res Med Pharmaceut Sci. 2016;6(2): 76-87. DOI: index.php/JIRMEPS/article/view/1592

39. Физиотерапия. Национальное руководство. Под. ред. Пономаренко ГН. - Москва: ГЭОТАР-Медиа; 2014:111-60.

40. Bryant HC, Roberts PR, Diprose P. Perioperative management of patients with cardiac implantable electronic devices. BJA Education. 2016;16(11):3 88-96. DOI: 10.1093/bjaed/mkw020.

41. Cenik F, Schoberwalter D, Keilani M, et al. Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators. Wien Klin Wochenschr. 2016; 128(21-22): 802-8. DOI: 10.1007%2Fs00508-016-1045-2.

42. Shenoy A, Sharma A, Achamyeleh F. Inappropriate implantable cardioverter defibrillators discharge related to electrical muscle stimulation in chiropractic therapy: A case report. Cardiol Ther. 2017;6(1): 139-43. DOI: 10.1007/s40119-017-0086-6.

43. Gruenwald W, Bhattacharrya M, Jansen D, et al. Electromagnetic analysis, characterization and discussion of inductive transmission parameters for titanium-based housing materials in active medical implantable devices. Materials. 2018;11(11):2089-116. DOI: 10.3390/ma11112089.

44. Yoshida S, Fujiwara K, Kohira S, et al. Electromagnetic interference of implantable cardiac devices from a shoulder massage machine. J Artif Organs. 2014;17(3):243-9. DOI: 10.1007/s10047-014-0765-1.

45. Cronin EM, Gray J, Abi-Saleh B, et al. Safety of repetitive nerve stimulation in patients with cardiac implantable electronic devices. Muscle Nerve. 2013;47: 840-44. DOI: 10.1002/mus.23707.

46. Powell BD, Asirvatham SJ, Perschbacher DL, et al. Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study. Pacing Clin Electrophysiol. 2012;35: 863-69. DOI: 10.1111/j.1540-8159.2012.03407.x.

47. Lister T, Grant L, Lee SM, et al. Electromagnetic interference from lasers and intense light sources in the treatment of patients with artificial pacemakers and other implantable cardiac devices. Lasers Med Sci. 2015;30(5):1619-22. DOI: 10.1007/s10103-013-1470-7.

48. Malm D, Hallberg LR. Patients’ experiences of daily living with a pacemaker. J Health Psychol. 2016;11(5):787-98. DOI: 10.1177%2F1359105306066642.

49. Santini L, Forleo GF, Santini M. Implantable devices in the electromagnetic environment. J Arrhythmia. 2013;29(6): 325-33. DOI: 10.1016/j.joa.2013.06.004.

50. Fleeman BE, Aleong RG. Optimal strategies to reduce inappropriate implantable cardioverter-defibrillator shocks. J Innov Card Rhythm Manag. 2019;10(4): 3623-32. DOI: 10.19102/icrm.2019.100403.

51. Gifford J, Larimer K, Thomas C, et al. Randomized controlled trial of perioperative ICD management: magnet application versus reprogramming. Pacing Clin Electrophysiol. 2014; 37(9): 1219-24. DOI: 10.1111/pace.12417.

52. Wilkoff BL, Fauchier L, Stiles MK. 2015 HRS/EHRA/ APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace. 2016;18(2): 159-83. DOI: 10.1093/europace/euv411.

53. Tiikkaja M, Alanko T, Lindholm H, et al. Experimental study on malfunction of pacemakers due to exposure to different external magnetic fields. J Interv Card Electrophysiol. 2012;34: 19-27. DOI: 10.1007/s10840-011-9651-4.

54. Stunder D, Seckler T, Joosten S, et al. In vivo study of electromagnetic interference with pacemakers caused by everyday electric and magnetic fields. Circulation. 2017;135(9): 907-9. DOI: 10.1161/CIRCULATIONAHA.116.024558.


Для цитирования:


Искендеров Б.Г., Лохина Т.В., Можжухина И.Н., Зайцева А.В. Возможности и меры безопасности использования физиотерапии у пациентов с имплантированными антиаритмическими устройствами. Вестник аритмологии. 2020;27(4):17-23. https://doi.org/10.35336/VA-2020-4-17-23

For citation:


Iskenderov B.G., Lokhina T.V., Mozhzhukhina I.N., Zaitseva A.V. Possibilities and safety measures for the use of physiotherapy in patients with implanted antiarrhythmic devices. Journal of Arrhythmology. 2020;27(4):17-23. (In Russ.) https://doi.org/10.35336/VA-2020-4-17-23

Просмотров: 47


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1561-8641 (Print)
ISSN 2658-7327 (Online)